Naproxen Heart Concerns Surface In Halted NIH Alzheimer’s Trial

The OTC industry is taking a wait-and-see approach regarding concerns about cardiovascular risks of naproxen (Bayer's Aleve) and other older NSAIDs rising in the wake of COX-2-related safety issues